CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer
Peiwei Yang, Yu Fan, Zheng Yao, Ding Xu, Hanmei Xu, Juan Zhang
Topics & Concepts
Triple-negative breast cancerCancer researchBreast cancerCD24Chimeric antigen receptorAntigenImmunotherapyCytotoxic T cellMedicineCancerImmunologyImmune systemBiologyIn vitroInternal medicineBiochemistryCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers